publication date: Dec. 20, 2010

In this issue: 

NCI disclosure of walk-out by Data and Safety Monitoring Board of the National Lung Screening Trial may be harmful, improper, experts say.

NCI Cancer Bulletin publicized board’s resignation over liability concerns.

NCI reassigns project officer John Gohagan.

Also in this 8-page issue: NCI, FDA open Web site for adverse event reporting.

Kansas Cancer Institute gets $15 million pledge, is renamed, and hires a new director in effort to win NCI center grant.

Funding opportunities listed.

Download (PDF 314KB)

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.